- Tumors896
- Pathologic Processes825
- Nervous System Diseases738
- Pathology653
- Cancer612
Any
<10 miles
<30 miles
<50 miles
<70 miles
Filter Results
Condition
- Tumors896
- Pathologic Processes825
- Nervous System Diseases738
- Pathology653
- Cancer612
Where are you looking?
How far are you willing to travel?Any
How old are you?
Trial Status
Recruiting statusPlacebo
Recruiting
Waitlist Available
Administration Type
Trial Phase
Biomarkers
Stage of Disease
- HER2 negative
- PD-L1 positive
- HER2 positive
- ER positive
- EGFR positive
- EGFR negative
- PR positive
- KRAS positive
- PD-L1 negative
- ALK negative
- BRAF positive
- ER negative
- PR negative
- BRAF negative
- ALK positive
- p16 positive
- ROS1 negative
- BRCA1 positive
- HLA positive
- CD20 positive
- HLA-A positive
- BRCA2 positive
- MET positive
- ROS1 positive
- TP53 positive
- PIK3CA positive
- IDH positive
- HR positive
- p16 negative
- KRAS negative
- MYC positive
- NRAS positive
- dMMR positive
- IDH negative
- MET negative
- MSI-H positive
- PALB2 positive
- RET positive
- ANA positive
- HBsAg positive
- MSS positive
- NF1 positive
- NTRK positive
- RB1 positive
- RET negative
- BCL2 positive
- BCR-ABL1 positive
- CD19 positive
- HLA negative
- HLA-A negative
- HPV negative
- HPV positive
- NTRK negative
- RB1 negative
- TP53 negative
- TROP2 negative
- TROP2 positive
- anti-dsDNA positive
- ctDNA positive
- pMMR positive
- ABCA4 positive
- BCL6 positive
- BRCA positive
- CCND1 positive
- CFTR positive
- COL7A1 positive
- FGFR2 positive
- NRAS negative
- PTEN positive
- RAS positive
- APP positive
- BRCA1 negative
- BRCA2 negative
- C5 positive
- DLL3 positive
- FLT3 positive
- FMR1 positive
- HRAS positive
- JAK2 positive
- MDM2 positive
- MGMT negative
- MSI-H negative
- PSEN1 positive
- PSEN2 positive
- Philadelphia chromosome positive
- PiZZ positive
- RAS negative
- RF positive
- RHO positive
- T790M positive
- dMMR negative
- 11q negative
- 11q positive
- AKT negative
- ALPL positive
- APOL1 positive
- ASXL1 positive
- ATM positive
- Aβ1-42 positive
- CD123 positive
- CLDN18.2 positive
- COL1A1 positive
- COL1A2 positive
- DMD positive
- EBV DNA positive
- EBV positive
- EZH2 positive
- Ex19del positive
- FGFR3 positive
- FLT3 negative
- FOXO1 fusion negative
- GPC3 positive
- GRN positive
- HBB positive
- HEXA positive
- HEXB positive
- HPV16 positive
- HR negative
- HbSS positive
- IGHV positive
- KIT positive
- L858R positive
- MGMT positive
- MLH1 positive
- MMR negative
- MMR positive
- MSH2 positive
- MSH6 positive
- MSS negative
- MTAP positive
- NF2 positive
- NPM1 positive
- NY-ESO-1 positive
- PD-1 negative
- PD-1 positive
- PDE6A positive
- PDE6B positive
- PIK3CA negative
- PIK3CD positive
- PIK3R1 positive
- PKLR positive
- PMS2 positive
- PTCH1 positive
- PTEN negative
- Philadelphia chromosome negative
- RAF positive
- SMN1 positive
- SPINK5 positive
- TET2 positive
- TTR positive
- UGT1A1 positive
- anti-AChR positive
- anti-MuSK positive
- anti-PLA2R positive
- anti-Ro autoantibodies positive
- anti-Ro/SSA positive
- anti-Sm positive
- anti-Smith positive
- other sickle cell syndrome variants positive
- t(11;14) positive
- 12 negative
- 12 positive
- 13q negative
- 13q positive
- 16p11.2 deletion positive
- 17p negative
- 17p positive
- 19q negative
- 19q positive
- 1p negative
- 1p positive
- 1p/19q co-deletion positive
- 1p/19q loss positive
- 1p36 deletion positive
- 46 XX karyotype positive
- 5q SMA positive
- 5q-autosomal recessive SMA positive
- AAVrh74 antibody titers negative
- ABL-class fusion positive
- ABL-class fusions positive
- ABO negative
- ABO positive
- ACVR1 positive
- AChR positive
- AChR-Ab positive
- ADAMTS-13 negative
- ADAMTS-13 positive
- AFP positive
- AKT positive
- AKT1 positive
- APOE e4 positive
- APOE ε4 positive
- AQP4 positive
- ATN1 positive
- Acetylcholine receptor antibody positive
- Anti-CCP-2 positive
- Anti-HBc IgM negative
- Anti-Ro/SS-A positive
- Anti-SSA (Ro) positive
- Anti-SSB (La) positive
- Gleason Score 10
- Gleason Score 6
- Gleason Score 7
- Gleason Score 8
- Gleason Score 9
- Grade 1
- Grade 2
- Grade 3
- Grade 4
- Stage IV
- Stage III
- Stage II
- Stage I
- 1927nm Fractional Thulium Laser Treatment
- Adjuvant Therapy (except reconstruction)
- Alopecia from Prior Treatment
- Anti-Seizure Medications (up to 2 types)
- Any Treatment for Pancreatic Cancer
- At least one prior tumor-directed therapy
- Avoidance of Activities That Cause Joint Pain
- Beovu
- Biologic Anti-Neoplastic Agent
- Branch Retinal Vein Occlusion (BRVO)
Trial Status
Recruiting statusPlacebo
Recruiting
Waitlist Available
Administration Type
Trial Phase
Biomarkers
Stage of Disease
4828 trials
1
2
3
…50